Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1338762 | 1.00 | MEN1 (0.56) | MEN1KMT2AALDH1A1MAPTNPC1 | |
| SCHEMBL21825774 | 0.87 | — | — | |
| SCHEMBL21825776 | 0.87 | — | — | |
| SCHEMBL25012007 | 0.86 | — | — | |
| SCHEMBL2221193 | 0.86 | — | — | |
| SCHEMBL3367044 | 0.85 | MEN1 (0.44) | MEN1KMT2A | |
| SCHEMBL771298 | 0.85 | — | — | |
| SCHEMBL6708480 | 0.85 | — | — | |
| SCHEMBL12245522 | 0.85 | — | — | |
| SCHEMBL21825814 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3862083-B1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM INC (KR) | 2023-03-08 | — | — | EP | disclosed |
| US-11420988-B2 | Catalyst for asymmetric hydrogenation of compound containing carbon double bond | GLACEUM, INC. (KR) | 2022-08-23 | — | — | US | disclosed |
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM, INC. (KR) | 2021-12-23 | — | — | US | disclosed |
| EP-3862083-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | Glaceum, Inc. (KR) | 2021-08-11 | — | — | EP | disclosed |
| US-8063205-B2 | Method for producing 2-oxazoline analogue or 1,3-oxazine analogue | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20090281309-A1 | METHOD FOR PRODUCING 2-OXAZOLINE ANALOGUE OR 1,3-OXAZINE ANALOGUE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1956012-A1 | METHOD FOR PRODUCING 2-OXAZOLINE ANALOGUE OR 1,3-OXAZINE ANALOGUE | National University Corporation Hokkaido University (JP) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281309-A1 | METHOD FOR PRODUCING 2-OXAZOLINE ANALOGUE OR 1,3-OXAZINE ANALOGUE | OXA1L, SULT1A1, DAO | MEN1 4342/4885KMT2A 2952/4885ALDH1A1 41/4885 |
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | INF2, DCX, HDHD5 | MEN1 2874/4885KMT2A 753/4885ALDH1A1 464/4885 |
| US-11420988-B2 | Catalyst for asymmetric hydrogenation of compound containing carbon double bond | INF2, DCX, HDHD5 | MEN1 2874/4885KMT2A 753/4885ALDH1A1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.